Works matching AU Min Kyong Moon


Results: 87
    1
    2
    3
    4

    Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3642, doi. 10.1111/dom.15705
    By:
    • Kim, Nam Hoon;
    • Moon, Jun Sung;
    • Lee, Yong‐ho;
    • Cho, Ho Chan;
    • Kwak, Soo Heon;
    • Lim, Soo;
    • Moon, Min Kyong;
    • Kim, Dong‐Lim;
    • Kim, Tae Ho;
    • Ko, Eunvin;
    • Lee, Juneyoung;
    • Kim, Sin Gon
    Publication type:
    Article
    5

    Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
    By:
    • Lim, Soo;
    • Han, Kyung Ah;
    • Yu, JaeMyung;
    • Chamnan, Parinya;
    • Kim, Eun Sook;
    • Yoon, Kun‐Ho;
    • Kwon, Sam;
    • Moon, Min Kyong;
    • Lee, Kwan Woo;
    • Kim, Dong‐Jun;
    • Kim, Mikyung;
    • Wongtanate, Manaj;
    • Kim, Eun Young;
    • Kim, Sung‐Ho;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    6
    7
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.

    Published in:
    Diabetes & Metabolism Journal, 2022, v. 46, n. 3, p. 464, doi. 10.4093/dmj.2021.0088
    By:
    • Soo Jin Yun;
    • In-Kyung Jeong;
    • Jin-Hye Cha;
    • Juneyoung Lee;
    • Ho Chan Cho;
    • Sung Hee Choi;
    • SungWan Chun;
    • Hyun Jeong Jeon;
    • Ho-Cheol Kang;
    • Sang Soo Kim;
    • Seung-Hyun Ko;
    • Gwanpyo Koh;
    • Su Kyoung Kwon;
    • Jae Hyuk Lee;
    • Min Kyong Moon;
    • Junghyun Noh;
    • Cheol-Young Park;
    • Sungrae Kim
    Publication type:
    Article
    24

    2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea.

    Published in:
    Diabetes & Metabolism Journal, 2021, v. 45, n. 4, p. 461, doi. 10.4093/dmj.2021.0156
    By:
    • Kyu Yeon Hur;
    • Min Kyong Moon;
    • Jong Suk Park;
    • Soo-Kyung Kim;
    • Seung-Hwan Lee;
    • Jae-Seung Yun;
    • Jong Ha Baek;
    • Junghyun Noh;
    • Byung-Wan Lee;
    • Tae Jung Oh;
    • Suk Chon;
    • Ye Seul Yang;
    • Jang Won Son;
    • Jong Han Choi;
    • Kee Ho Song;
    • Nam Hoon Kim;
    • Sang Yong Kim;
    • Jin Wha Kim;
    • Sang Youl Rhee;
    • You-Bin Lee
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.

    Published in:
    Diabetes & Metabolism Journal, 2019, v. 43, n. 4, p. 398, doi. 10.4093/dmj.2019.0137
    By:
    • Mee Kyoung Kim;
    • Seung-Hyun Ko;
    • Bo-Yeon Kim;
    • Eun Seok Kang;
    • Junghyun Noh;
    • Soo-Kyung Kim;
    • Seok-O Park;
    • Kyu Yeon Hur;
    • Suk Chon;
    • Min Kyong Moon;
    • Nan-Hee Kim;
    • Sang Yong Kim;
    • Sang Youl Rhee;
    • Kang-Woo Lee;
    • Jae Hyeon Kim;
    • Eun-Jung Rhee;
    • SungWan Chun;
    • Sung Hoon Yu;
    • Dae Jung Kim;
    • Hyuk-Sang Kwon
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Monotherapy in Patients with Type 2 Diabetes Mellitus.

    Published in:
    Diabetes & Metabolism Journal, 2017, v. 41, n. 5, p. 349, doi. 10.4093/dmj.2017.41.5.349
    By:
    • Sang Youl Rhee;
    • Hyun Jin Kim;
    • Seung-Hyun Ko;
    • Kyu-Yeon Hur;
    • Nan-Hee Kim;
    • Min Kyong Moon;
    • Seok-O Park;
    • Byung-Wan Lee;
    • Kyung Mook Choi;
    • Jin Hwa Kim
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.

    Published in:
    Journal of Diabetes Investigation, 2013, v. 4, n. 5, p. 466, doi. 10.1111/jdi.12074
    By:
    • Son, Jang Won;
    • Kim, Dong Jun;
    • Lee, Chang Beom;
    • Oh, Seungjoon;
    • Song, Kee‐Ho;
    • Jung, Chan Hee;
    • Mok, Ji Oh;
    • Kim, Jong Hwa;
    • Moon, Min Kyong;
    • Choi, Kyung Mook;
    • Cho, Jae Hyoung;
    • Choi, Sung Hee;
    • Kim, Soo Kyung;
    • Park, Kang Seo;
    • Kim, Hye Soon;
    • Kim, In Joo;
    • Kim, Young Il;
    • Kim, Hae Jin;
    • Kim, Sang Yong;
    • Kim, Sungrae
    Publication type:
    Article
    47
    48
    49
    50